Anticoagulation Considerations in Renally-Impaired Patients with NVAF or VTE: Case Simulations and Commentary

Anticoagulation Considerations in Renally-Impaired Patients with NVAF or VTE: Case Simulations and Commentary

Anticoagulation for renally-impaired individuals with non-valvular atrial fibrillation (NVAF) or venous thromboembolism (VTE) often entails balancing the risk of vascular events (eg, stroke, pulmonary embolism) with the dangers of excess bleeding. In this CME Outfitters BriefCase series, two expert clinicians a cardiologist and a nephrologist view 4 short patient care videos in real-time. After each vignette, they provide frank and candid commentary punctuated by clinical tips and pearls you can use in your own practice. Among the topics covered: Should stroke and VTE prophylaxis take precedent over the risk of bleeding? Should advanced age and risk of falls be contraindications to anticoagulation? Are direct oral anticoagulants (DOACs) considered first-line in 2024 and for which patients? Does chronic kidney disease (CKD) warrant lower DOAC and/or warfarin doses in patients with NVAF or VTE? How does an individual s social determinants of health inform shared decision-making when it comes to choices in anticoagulation? Please join us for Anticoagulation Considerations in Renally-Impaired Patients with NVAF or VTE: Case Simulations and Commentary and learn how to strike the right balance for your own renally-impaired patients with NVAF or VTE.

  • Provider:CME Outfitters, LLC
  • Activity Link: https://www.cmeoutfitters.com/activity/anticoagulation-considerations-in-renally-impaired-patients-with-nvaf-or-vte-case-simulations-and-commentary/
  • Start Date: 2024-02-01 06:00:00
  • End Date: 2024-02-01 06:00:00
  • Credit Details: IPCE Credits: 0.75 hours
    AAPA Category 1 Credit™️: 0.75 hours
    AMA PRA Category 1 Credit™️: 0.75 hours
    Nursing: 0.75 hours
    Pharmacy: 0.75 hours
  • MOC Credit Details: ABIM - 0.75 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 0 - Is Kind Support: False Source: Pfizer (Any division) - Amount: 0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Internal Medicine
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.